Epitope-Imprinted Field-Effect Transistors Overcome Debye Length Limitations for Label-Free Protein Detection.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40183349.
- Also identified by DOI 10.1021/acs.nanolett.5c00454.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Graphene-based field-effect transistor (GFET) biosensors face limitations in detecting charged analytes due to ionic screening (Debye screening effect). This limitation restricts their ability to detect charged target analytes <i>in situ</i> in physiological solutions. To overcome this challenge, we present a non-destructive van der Waals (vdW) integration of an epitope molecular-imprinted membrane (EMIM) with a GFET biosensor. This innovative vdW-heterostructured biosensor, termed the EMIM-Chip, features a 3.3 ± 1.7 nm thin EMIM dielectric layer self-assembled on the graphene surface. The EMIM layer, featuring specifically imprinted cavities, replaces antibodies and effectively mitigates ionic screening. This innovation enables rapid <i>in situ</i> detection of Alzheimer's disease (AD) biomarker Aβ proteins (50 aM-5 pM) in purified samples and patient plasma/urine within minutes. Notably, these sensors retain their functionality even after 30 days of environmental storage, positioning our approach as a promising foundation for future medical tool development.
Medical subject headings
- Biosensing Techniques
- Transistors, Electronic
- Molecular Imprinting
- Epitopes
- Amyloid beta-Peptides
- Graphite
- Alzheimer Disease